| (210) | Number of the EPO application | 17849479 |
| (220) | Filing date of the EPO application | 2017.09.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2024, 2024.06.19 |
| (110) | EPO patent number | 3510023 |
| (21) | Number of the application | e 2019 0785 |
| (71) | Name(s) of applicant(s), code of the country | Pharmakea, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LONERGAN David, US;
HOLME Kevin Ross, US;
ROWBOTTOM Martin W., US; |
| (73) | Name(s) of owner(s), code of the country | Pharmakea, Inc., US; |
| (54) | Title of the invention | CRYSTALLINE FORMS OF A LYSYL OXIDASE-LIKE 2 INHIBITOR AND METHODS OF MAKING |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/12 (2006.01.01); C07D 207/12 (2006.01.01); C07C 309/66 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 35/00 (2006.01.01); A61P 43/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.08.31 |
| (30) | Priority | 201662384596 P, 2016.09.07, US |
| (86) | International application | PCT/US2017/050332, 2017.09.06 |
| (87) | International publication | WO 2018/048943, 2018.03.15 |